TMCnet News

Research and Markets: Sickle Cell Disease Pipeline Insights Report 2015
[January 27, 2015]

Research and Markets: Sickle Cell Disease Pipeline Insights Report 2015


Research and Markets (http://www.researchandmarkets.com/research/pd4vt8/sickle_cell) has announced the addition of the "Sickle Cell Disease-Pipeline Insights, 2014" subscription to their offering.

This Sickle Cell Disease-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Sickle Cell Disease.

This report provides information on the therapeutic development based on the Sickle Cell Disease dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, iscovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.



The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:


  1. Sickle Cell Disease Overview
  2. Sickle Cell Disease Pipeline Therapeutics
  3. Sickle Cell Disease Therapeutics under Development by Companies
  4. Sickle Cell Disease Late Stage Products (Filed and Phase III)
  5. Comparative Analysis
  6. Sickle Cell Disease Mid Clinical Stage Products (Phase II)
  7. Comparative Analysis
  8. Sickle Cell Disease Early Clinical Stage Products (Phase I and IND Filed)
  9. Comparative Analysis
  10. Sickle Cell Disease Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Sickle Cell Disease - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Sickle Cell Disease - Discontinued Products
  19. Sickle Cell Disease - Dormant Products
  20. Companies Involved in Therapeutics Development for Sickle Cell Disease
  21. Appendix

For more information visit http://www.researchandmarkets.com/research/pd4vt8/sickle_cell


[ Back To TMCnet.com's Homepage ]